46.46.Z - Wholesale trade of pharmaceutical and medical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.74.Z - Retail sale of medical and orthopedic products
64.20.Z - Holding company activities and companies raising funds for other entities
68.20.Z - Rental and management of own or leased real estate
70.10.Z - Head office activities
72.19.Z - Scientific research and development activities
73.1 - Advertising
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 8,4 | 19,9 | 21,3 | 6,8 |
EBITDA | 9,4 | 23,1 | 25,4 | 9,9 |
Short time liabilities | 9,1 | 24,8 | 30,2 | 21,9 |
Equity capital | 76,7 | 92,4 | 109,1 | 18,1 |
Operating profit (EBIT) | 8,7 | 19 | 20,6 | 8,3 |
Assets | 90,6 | 130,3 | 158,4 | 21,6 |
Net profit (loss) | 6,6 | 15,6 | 16,7 | 6,7 |
Cash | 11 | 7,5 | 17,2 | 128,6 |
Liabilities and provisions for liabilities | 13,9 | 37,9 | 49,4 | 30,4 |
Net income from sale | 135,7 | 207,5 | 271,3 | 30,7 |
Working assets | 65,2 | 104,8 | 134,8 | 28,6 |
Depreciation | 0,7 | 4 | 4,8 | 17,5 |
% | % | % | p.p. | |
Profitability of capital | 8,6 | 16,9 | 15,3 | -1,6 |
Equity capital to total assets | 84,7 | 70,9 | 68,8 | -2,1 |
Gross profit margin | 6,2 | 9,6 | 7,8 | -1,8 |
EBITDA Margin | 6,9 | 11,1 | 9,3 | -1,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 24 | 44 | 41 | -3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane